ArticleFrontiers in public health2026
Willingness to receive cross-border human papillomavirus vaccination among Chinese male university students: a cross-sectional study with statistical indirect-association analysis.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Human papillomavirus (HPV) vaccination is an important strategy for preventing HPV-related disease among males. Access to male HPV vaccination may involve cross-border health seeking for some university students in mainland China. This study estimated willingness to receive cross-border HPV vaccination among Chinese male university students and examined associations of HPV-related disease recognition, awareness of cross-border vaccination availability, and demographic and informational characteristics with willingness. Methods: A cross-sectional anonymous online survey was conducted between September 2025 and March 2026 among 4,260 male university students in mainland China, Hong Kong, Macao, and overseas. The primary outcome was willingness to travel at personal expense to Hong Kong or Macao for HPV vaccination. HPV-related disease recognition was assessed using four conditions with established HPV associations: anogenital warts, penile cancer, anal cancer, and oropharyngeal cancer. Multivariable logistic regression estimated adjusted odds ratios (aORs) and 95% confidence intervals (CIs). Results: Of 4,260 participants, 3,182 (74.69%) reported willingness to receive cross-border HPV vaccination. Participants with a disease-recognition gap had substantially lower adjusted odds of willingness than those identifying at least one condition (aOR = 0.041, 95% CI: 0.017-0.095; Conclusion: Willingness to receive cross-border HPV vaccination was reported by approximately three-quarters of participants. Recognition of established HPV-related male diseases and awareness of cross-border vaccination availability were associated with willingness. The cross-sectional design precludes causal inference. Longitudinal and intervention studies are needed to determine whether male-focused HPV education and service-navigation strategies increase actual vaccine uptake.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.